Skip to main content
Equibles
EVFM logo

EVFM · Evofem Biosciences, Inc. · Webcasts, Transcripts & Audio

Track EVFM — free

Use EVFM with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research EVFM.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$57.50 At close · Aug 11
Rebalance outlook locked
Going-concern doubt — flagged Aug 14, 2026

Substantial doubt about the company's ability to continue as a going concern.

“The Company has concluded that these circumstances and the uncertainties associated with the Company's ability to obtain additional equity or debt financing on terms that are favorable to the Company, or at all, and otherwise succeed in its future operations raise substantial doubt about the Company's ability to continue as a going concern.”
View the 10-Q filed Aug 14, 2026
Market Cap
$1.06M
Shares
132.53M
Volume · Aug 11 58.6K Avg daily vol (3M) —

Evofem Biosciences, Inc. Webcasts

Earnings calls, investor updates, investor days and conferences for Evofem Biosciences, Inc. (EVFM), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP →

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
· $ −$19.15M '20 Q1 20-05-06 · $ −$52.67M '20 Q2 20-08-04 · $278,000 −$29.90M '20 Q3 20-11-09 · $168,000 −$40.60M '20 Q4 21-03-04 · $1.10M −$46.15M '21 Q1 21-05-06 · $1.86M −$33.43M '21 Q2 21-08-11 ▲2025% $3.57M −$51.55M '21 Q4 22-03-03 ▲284.7% $4.25M −$31.89M '22 Q1 22-05-04 LATEST ▲224.9% $6.03M −$125.98M '22 Q2 22-08-04
Earnings call
FY22 · Q2
2022-08-04
Evofem Biosciences, Inc. (EVFM) Q2 2022 Earnings Call
Revenue
$6.03M
▲ 224.9% YoY
Diluted EPS
$-580.48
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-04
Evofem Biosciences, Inc. (EVFM) Q1 2022 Earnings Call
Revenue
$4.25M
▲ 284.7% YoY
Diluted EPS
$-360.00
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-03-03
Evofem Biosciences, Inc. (EVFM) Q4 2021 Earnings Call
Revenue
$3.57M*
▲ 2025% YoY
Rev · 7q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q2
2021-08-11
Evofem Biosciences, Inc. (EVFM) Q2 2021 Earnings Call
Revenue
$1.86M
Diluted EPS
$-501.25
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-06
Evofem Biosciences, Inc. (EVFM) Q1 2021 Earnings Call
Revenue
$1.10M
Diluted EPS
$-1057.50
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-03-04
Evofem Biosciences, Inc. (EVFM) Q4 2020 Earnings Call
Revenue
$168,000*
Rev · 4q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-11-09
Evofem Biosciences, Inc. (EVFM) Q3 2020 Earnings Call
Revenue
$278,000
Diluted EPS
$-693.75
Rev · 4q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-08-04
Evofem Biosciences, Inc. (EVFM) Q2 2020 Earnings Call
Revenue
$
Diluted EPS
$-1706.25
Rev · 3q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-05-06
Evofem Biosciences, Inc. (EVFM) Q1 2020 Earnings Call
Revenue
$
Rev · 2q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY19 · Q4
2020-03-12
Evofem Biosciences, Inc. (EVFM) Q4 2019 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Showing 1–10 of 10 webcasts
Key facts CIK 1618835 CUSIP 30048L302 Visit website Investor relations